Has a single UPC action yet been stayed in view of a parallel EPO opposition? The court is very reluctant to be delayed by EPO opposition proceedings and remains patentee-friendly in its general approach.
READ MORE
As of 1 January 2025 some changes to UK Supplementary Protection Certificate (SPC) practice will come into force in relation to human medicines.
READ MORE
In a trade mark infringement case brought by Shorts International Limited (“SIL”) against Google LLC (“Google”) in the High Court of England and Wales, a decision by Michael Tappin KC towards the end of 2024 gave a salutary reminder regarding the scope of trade marks containing descriptive elements.
READ MORE
In a recent decision, the UPC Court of Appeal ruled on the correction of errors in a patent by interpretation. This case, concerning Alexion Pharmaceuticals’ patent (EP3167888), underscores the importance of precise drafting and consistency in arguments used during patent litigation.
READ MORE
Icelandic performance artist Odee Friðriksson’s work, We’re Sorry—an attempt to tackle corporate wrongdoing—has floundered in the High Court. Dehns Trade Mark Attorney, Tiernan Graham, discusses.
READ MORE
We look at the general principles of patent working requirements and take a closer look at some jurisdictions which have more stringent requirements on patent working post-grant. We also look at what you can do in order to prevent a third party from accessing your patented technology.
READ MORE
Plausibility after Warner-Lambert and G2/21: Paul Harris, Head of Litigation at Dehns, provides a case analysis of Sandoz and Teva v Bristol Myers Squibb – Court of Appeal.
Tesco Shown a Yellow (Club) Card: Daniel Wheatley, Trade Mark Assistant at Dehns provides a case analysis of Lidl Great Britain Ltd & Anor v Tesco Stores Ltd & Anor [2023] EWHC 873 (Ch).
Future royalty term considerations at early stage R&D licences: In this article, David Pountney, Senior Associate, Litigation at Dehns provides a case analysis of AstraZeneca UK Ltd v Tesaro Inc.
Join us in celebrating the work of trailblazing women around the world and in raising awareness about why it is so important to encourage more women to participate in the IP system, to protect their valuable IP and commercialise their ideas.
To celebrate our own “Women in IP” we’re taking this opportunity to introduce Hanna Dzieglewska – Head of Dehns Biotechnology team.
Join us in celebrating the work of trailblazing women around the world and in raising awareness about why it is so important to encourage more women to participate in the IP system, to protect their valuable IP and commercialise their ideas.
To celebrate our own “Women in IP” we’re taking this opportunity to introduce Elaine Deyes – Head of Dehns Trade Mark Group.
The theme for World Intellectual Property Day 2023 is Women and IP: Accelerating Innovation and Creativity. To highlight the innovative women in our network, we interviewed some of our contacts who are working on innovative solutions that challenge the status quo.
The theme for World Intellectual Property Day 2023 is Women and IP: Accelerating Innovation and Creativity. To highlight the innovative women in our network, we interviewed a few of our contacts who are working on innovative solutions that challenge the status quo.
Dehns have previously discussed the concept of plausibility and how much experimental data is needed for patent applications in Europe, which is relevant to both sufficiency and inventive step. In an ideal world all the relevant data would be contained in the application as filed. However, this is not always possible, particularly if new prior art is found during prosecution that necessitates the formulation of new comparative data to support an inventive step.
The EPO Enlarged Board of Appeal has now issued their decision on G2/21, a case which was intended to decide whether evidence submitted after the filing date could be used to support inventive step.
Subscribe here for updates on IP news, events and webinars.
|